Informa's 10th Annual Recombinant Antibodies Meeting will gather Europe's antibody community to discuss various topics including: how to improve effector functions and extend half life; the engineering of novel antibody formats and fragments; antibody drug conjugates, bispecific antibodies and fusion proteins; antibody engineering and its translation into clinical applications; and obtaining patents for new technologies.
David Blakey will present on "Introduction for Day 3 of Recombinant Antibodies Meeting."
Added by MedImmune on May 5, 2011